April 2025

MIMS Full Prescribing Update

New / Revised

Product Name

Section changed
New Amiodarone Hydrochloride Solution for Injection/Infusion (UK)
New Amoxicillin-WGR Capsules
New Amoxicillin-WGR Powder for Suspension
New APOHealth Dexchlorpheniramine Allergy Relief
New APOHealth Paracetamol Pain Relief
New APOHealth Paracetamol Pain Relief (bottle)
New ARX-Ticagrelor
New Azithromycin Tablets, USP (Precision Dose,USA)
New Azithromycin-WGR
New Bimatoprost-WGR
New Blooms The Chemist Paracetamol Pain Relief
New Carboplatin Injection, USP (Ingenus,USA)
New Chemists' Own Paracetamol Extra
New Chemists' Own Paracetamol Pain Relief
New Clindamycin-WGR
New Clopidogrel-WGR
New Cyclizine Juno
New Dapsomed
New Entecavir-WGR
New Esomeprazole-WGR
New Finasteride-WGR 1 mg
New Finasteride-WGR 5 mg
New Fluconazole-WGR
New Fluorouracil Injection, USP (Alembic, USA)
New Gabapentin-WGR
New Irbesartan HCTZ-WGR
New Irbesartan-WGR
New Isosorbide MR-WGR
New Isotretinoin-WGR
New Ivabradine-WGR
New Latanoprost-WGR
New Maraviroc Waymade
New Nyxoid (UK) (Link)
New Omjjara
New Opfolda
New Phentermine XR-WGR
New Pombiliti
New Rabeprazole-WGR
New Rocuronium-hameln
New Sertraline-WGR
New Solifenacin-WGR
New Tadalafil-WGR
New Tibolone-WGR
New Xofluza
Revised 0.9% Sodium Chloride Injection, USP in Viaflo plastic container (Baxter, USA) New Presentation of Brand already available
Revised Actos Nature and Contents of Container, Pharmaceutical Form
Revised Amitriptyline Viatris Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Anagrelide ARX Product Name change, Qualitative and Quantitative Composition
Revised Anagrelide Lupin Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Anterone 100 Pharmacological Properties, Physicochemical Properties
Revised APO-Atorvastatin Adverse Effects (Undesirable Effects)
Revised APO-Ezetimibe Special Warnings and Precautions for Use
Revised APO-Fentanyl Adverse Effects (Undesirable Effects)
Revised APOHealth Paracetamol Pain Relief New Brand of Product already available, Sponsor
Revised APO-Levetiracetam Oral Solution Adverse Effects (Undesirable Effects)
Revised APO-Rizatriptan ODT (was Rizatriptan ODT Apotex) List of Excipients
Revised APO-Sertraline Adverse Effects (Undesirable Effects)
Revised APO-Topiramate Fertility, Pregnancy and Lactation
Revised APX-Metformin Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised APX-Sildenafil (was Sildenafil APOTEX) Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Ataris Special Warnings and Precautions for Use
Revised Avanza TGA Date
Revised Belkyra Adverse Effects (Undesirable Effects)
Revised Bisoprolol Sandoz TGA Date
Revised Blooms Escitalopram Nature and Contents of Container
Revised Brenda-35 ED Special Warnings and Precautions for Use
Revised Bufomix Easyhaler Special Warnings and Precautions for Use
Revised Carmustine Medsurge TGA Date
Revised Cephazolin Viatris Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Chemists' Own Paracetamol 500 mg Tablets New Brand of Product already available, Poisons Schedule, Sponsor
Revised Cidala Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Clarithromycin Sandoz Contraindications, Interactions with Other Medicines and Other Forms of Interactions
Revised Combivir Nature and Contents of Container
Revised DBL Methotrexate Injection Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Diamox Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Diprosone TGA Date
Revised Donepezil Sandoz Adverse Effects (Undesirable Effects), Qualitative and Quantitative Composition
Revised Dotagraf Fertility, Pregnancy and Lactation
Revised Dupixent Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Dymista Allergy Special Warnings and Precautions for Use
Revised Eleuphrat TGA Date
Revised Elocon Alcohol Free Cream TGA Date
Revised Elocon Ointment and Lotion TGA Date
Revised Eloctate Shelf Life
Revised Empaveli Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Nature and Contents of Container, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Endep Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Enlafax-XR Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Epiramax Fertility, Pregnancy and Lactation
Revised Esomeprazole RBX Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use
Revised Esomeprazole Sandoz Hp7 Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use
Revised Ezemichol Dose and Method of Administration, Special Warnings and Precautions for Use
Revised Femoston 1/10 Sponsor, TGA Date
Revised Femoston 2/10 Sponsor, TGA Date
Revised Femoston-Conti Sponsor, TGA Date
Revised Fentanyl Sandoz Adverse Effects (Undesirable Effects)
Revised Fibrovein Dose and Method of Administration, Nature and Contents of Container, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use, Sponsor, Therapeutic Indications
Revised Flagyl Adverse Effects (Undesirable Effects), New contraindication, Special Warnings and Precautions for Use
Revised Flagyl S Adverse Effects (Undesirable Effects), New contraindication, Special Warnings and Precautions for Use
Revised Fluconazole Sandoz Adverse Effects (Undesirable Effects)
Revised Fluorouracil Accord Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Formet Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Formet 500 Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Formet 850 Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Frisium TGA Date
Revised Gardasil 9 Pharmacological Properties
Revised Glaumox Powder for Injection Adverse Effects (Undesirable Effects), Nature and Contents of Container, Special Warnings and Precautions for Use
Revised Hemosol B0 Dose and Method of Administration
Revised Hizentra TGA Date
Revised Humira Adverse Effects (Undesirable Effects), Nature and Contents of Container
Revised Ikervis Nature and Contents of Container
Revised Imfinzi Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Implanon NXT TGA Date
Revised Isotretinoin Lupin Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Jemperli Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Special Warnings and Precautions for Use
Revised Kalydeco Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Keytruda Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Kymriah Adverse Effects (Undesirable Effects), Boxed Warnings, Special Warnings and Precautions for Use
Revised L.C.E. Sandoz TGA Date
Revised Lanoxin List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Sponsor
Revised Leflunomide Generichealth Special Warnings and Precautions for Use
Revised Levetiracetam SZ Adverse Effects (Undesirable Effects)
Revised Lucrin Depot Paediatric Prefilled Dual Chamber Syringe (PDS) Injection 3 Month Adverse Effects (Undesirable Effects)
Revised Lucrin Depot Prefilled Dual Chamber Syringe (PDS) Injection Adverse Effects (Undesirable Effects)
Revised Lunava Special Warnings and Precautions for Use
Revised Marvelon 28 TGA Date
Revised Maxalt TGA Date
Revised Melatonin ARX Sponsor
Revised Melotin (MR) Sponsor
Revised Melotin MR Sponsor
Revised MersynoNight Night Time Pain Relief Adverse Effects (Undesirable Effects)
Revised Mesasal Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Methoblastin Interactions with Other Medicines and Other Forms of Interactions, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use
Revised Methoblastin (bottle) Interactions with Other Medicines and Other Forms of Interactions, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use
Revised Metrogyl Sponsor
Revised Modafinil Mylan Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Moxifloxacin Kabi Boxed Warnings, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Noradrenaline Medsurge TGA Date
Revised Norflex Nature and Contents of Container
Revised NorLevo-1 Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Novasone TGA Date
Revised Noxicid Caps Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use
Revised NuvaRing TGA Date
Revised Ocaliva Dose and Method of Administration, New contraindication, Special Warnings and Precautions for Use
Revised Ogivri TGA Date
Revised Olmesartan/HCT Sandoz TGA Date
Revised Omacor Pharmaceutical Form
Revised Opdivo Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Otodex Sponsor
Revised Oxycodone Sandoz Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use
Revised Padcev Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Palexia IR Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Overdose
Revised Palexia SR Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Overdose
Revised Panadol Rapid Adverse Effects, Contraindications, Indications, Precautions
Revised Pharmacor Atorvastatin Adverse Effects (Undesirable Effects)
Revised Pharmacy Action Paracetamol Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Phoxilium Dose and Method of Administration
Revised Polivy Special Warnings and Precautions for Use
Revised Potassium Chloride Aborns TGA Date
Revised Premarin Tablets Pharmacological Properties, Special Warnings and Precautions for Use
Revised Provera Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Rabeprazole Sun Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Rabipur Dose and Method of Administration, Nature and Contents of Container
Revised Ralovera Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Renitec TGA Date
Revised Rinvoq Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Special Warnings and Precautions for Use
Revised Riximyo Dose and Method of Administration
Revised Rybrevant Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Salofalk Enemas Dose and Method of Administration, Name of Medicine, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use
Revised Salofalk Granules TGA Date
Revised Salofalk Tablets TGA Date
Revised Sandoz Venlafaxine XR Sponsor
Revised Saphris TGA Date
Revised Sertra Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use
Revised Sertraline-TIH Adverse Effects (Undesirable Effects)
Revised Sevoflurane Sandoz TGA Date
Revised Sintetica Baclofen Intrathecal Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use
Revised Skyrizi Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Stalevo TGA Date
Revised Stemetil TGA Date
Revised Sutent Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Syntocinon Sponsor
Revised Tadacip Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Tamate Fertility, Pregnancy and Lactation, Overdose, Special Warnings and Precautions for Use
Revised Tirofiban Juno TGA Date
Revised Tobra-Day Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Topiramate Sandoz Fertility, Pregnancy and Lactation
Revised Tramadol Sandoz SR TGA Date
Revised Tramal Interactions with Other Medicines and Other Forms of Interactions, Overdose
Revised Trulicity Special Warnings and Precautions for Use
Revised Tygacil Adverse Effects (Undesirable Effects), Pharmacological Properties
Revised Vasafil Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Velabine Adverse Effects (Undesirable Effects), Name of Medicine
Revised Venclexta Nature and Contents of Container
Revised Viatocinon Sponsor
Revised Vinorelbine Ebewe Adverse Effects (Undesirable Effects)
Revised Vyepti Adverse Effects (Undesirable Effects)
Revised Xeljanz Special Warnings and Precautions for Use
Revised Xtandi Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Yervoy Adverse Effects (Undesirable Effects)
Revised Zetlam Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Zocor TGA Date
Revised Zumenon Sponsor
Revised Zyprexa IM TGA Date
Deleted Bortezomib Baxter
Deleted Cipla Bisoprolol
Deleted Flixotide Nebules
Deleted Flolan
Deleted Gemcitabine Kabi
Deleted Levitra
Deleted Provive MCT-LCT 1%

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Suite 1602, Level 16
44 Market Street
Sydney NSW 2000
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au